Thales Confirms Its Key Role to Provide Cybersecurity for Galileo Second Generation to Meet Tomorrow's Threats
20.7.2023 11:00:00 EEST | Business Wire | Press release
Europe’s largest satellite system security monitoring programme
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230720371000/en/
Sylvain Loddo - Head of Galileo Ground Segment Management Office, Ennio Guarino - Head of Galileo and EGNOS Programme Department, Lionel SALMON – Cybersecurity of Information Systems Director and Alexandra POREZ – Thales GALILEO Programme Director. ©Thales
As part of G2G IOV SECMON, Thales is leading the consortium, including the Italian group Leonardo, to expand the scope of security monitoring and include the new assets in the G2G system. It will also introduce automated incident response and network traffic monitoring. In addition, the solution will be capable of storing significant amounts of incident response data. To meet this challenge, Thales will deliver a solution built on a scalable, flexible architecture derived from its Cybels range of security supervision products and incorporating big data capabilities.
A cybersecurity contract for better protection from quantum threats
New threats from quantum computers capable of breaking existing cryptographic algorithms have the potential to compromise long-term data security. Thales has been tasked by ESA within the consortium it leads to draw on its world-renowned cryptography expertise.
Under the “G2G System Engineering and Technical Assistance for security and PRS” contract, Thales will specify and verify the new cybersecurity for the G2G system – taking into account new threats to space systems, security maintenance requirements, improvements to the PRS service for government users– and prepare for system certification. One of the major challenges is to ensure a smooth transition from G1G to G2G while maintaining the level of security and performance offered by the G1G system for member states.
“Thales thanks ESA, EUSPA and the European Commission for its continued confidence in the Group’s expertise in space systems and cybersecurity for critical systems. These security contracts for Galileo Second Generation will bring Europe a more robust system with better protection from quantum threats – a major challenge for the space industry in the decades ahead – and will draw on the Group’s unparalleled big data expertise to provide more effective security monitoring of the world’s leading satellite positioning system,” said Pierre-Yves Jolivet, VP Cyber Solutions, Thales.
The cybersecurity of satellite systems has become a growing concern for satellite operators and space agencies, particularly against a backdrop of geopolitical tensions. Today, thousands of satellites are in orbit, and it is estimated that 10,000 more will be added over the next 10 years, due to the multiplication of uses, from everyday life with the Internet of Things to defense applications.
Through the signing of these two contracts, Thales's expertise in scalable and flexible architecture and security equipment and protection against cyberattacks will enable the G2G program to strengthen its ability to detect and respond to new cyberthreats. The end-to-end solution proposed by Thales experts will contribute to the development of greater security and resilience of satellites.
In parallel, Thales Alenia Space has been notified of major contracts to design and build with its European consortium the G2G Ground Mission Segment and execute System Engineering Activities. The company is also providing 6 of the 12 satellites of the constellation.
Cybersecurity at Thales
As a global leader in cybersecurity, Thales is involved at every level of the cyber value chain, offering solutions ranging from risk assessment to protection of critical infrastructure, supported by comprehensive threat detection and response capabilities. Its offer is built around three families of cybersecurity products and services, which generated sales of €1.5bn in 2022:
- Global security products around the CipherTrust Data Security Platform the SafeNet Trusted Access Identity & Access Management as a service solution, and the broader cloud protection & licensing offerings
- Sovereign protection products including encryptors and sensors to protect critical information systems
- Cybels solutions portfolio, a complete suite of cybersecurity services including risk assessment, training and simulation, and cyberattack detection and response
Drawing on more than 40 years of experience in cybersecurity and space activities, Thales applies the principles of "cybersecurity by design" to the products it develops for satellite operators and space agencies. With more than 4,000 cybersecurity specialists, Thales helps to ensure the security of satellite systems for national and European space programmes – in particular Europe's Galileo satellite navigation programme – and at the international level. With its combined expertise in cutting-edge satellite systems and cybersecurity solutions relying on the latest military technologies, Thales offers governments, institutions and enterprise customers a comprehensive range of cybersecurity solutions to guarantee robust protection of all the elements of a space system. In April 2023, Thales demonstrated its expertise in offensive security at CYSAT, managing to take remote control of an ESA demonstration satellite, in order to anticipate and respond to current and future threats.
About Galileo
Galileo is Europe’s global navigation satellite system (GNSS). Operational since 15 December 2016, Galileo’s initial services are fully interoperable with GPS, while offering users an expanded range of performance and service levels, along with far more accurate positioning. All smartphones sold in the European Single Market are now guaranteed Galileo-enabled. In addition, Galileo is making a difference across the fields of rail and maritime transportation, agriculture, financial timing services and rescue operations. Unlike the American GPS, Russian GLONASS and Chinese Beidou satellite navigation systems, which are operated by the armed forces, Galileo is the world’s only GNSS system under civilian control.
To date, Galileo is scheduled to comprise a constellation of 38 first-generation satellites, transmitting stations for satellite control and telemetry, transmitting stations for mission data, two security management centres (in Saint-Germain-en-Laye and Madrid), two system control centres (Oberpfaffenhofen and Fucino) and 16 stations for orbit control and clock synchronisation.
Galileo Second Generation is designed to be flexible and adapt to user needs in the decades ahead. It will also be more robust to withstand the challenges of a constantly changing world, especially the threats of jamming and cybercrime. With unrivalled accuracy and additional authentication capabilities, Galileo will be the world’s most advanced GNSS system.
|
About Thales Thales (Euronext Paris: HO) is a global leader in advanced technologies within three domains: Defence & Security, Aeronautics & Space, and Digital Identity & Security. It develops products and solutions that help make the world safer, greener and more inclusive. The Group invests close to €4 billion a year in Research & Development, particularly in key areas such as quantum technologies, Edge computing, 6G and cybersecurity. Thales has 77,000 employees in 68 countries. In 2022, the Group generated sales of €17.6 billion.
|
More information:
Cybersecurity solutions | Thales Group
Cybersecurity in space: How Thales is meeting the challenges ahead | Thales Group
Cyberthreat hitmap (thalesgroup.com)
1 « Public Regulated Service » refers to Galileo’s service for governmental use
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230720371000/en/
Contact information
PRESS CONTACTS
Thales Media Relations
Marion Bonnet
+33 (0)6 60 38 48 92
marion.bonnet@thalesgroup.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 17:19:00 EEST | Press release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 17:15:00 EEST | Press release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 16:00:00 EEST | Press release
inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and
Brenus Pharma's Novel In Vivo Immunotherapy STC-1010 Shows Safety, Activating T Cells in First-Line MSS Metastatic Colorectal Cancers With 2 Complete Responses.23.10.2026 15:50:00 EEST | Press release
Brenus Pharma, a clinical-stage biotech company, announced first data from the Phase Ia dose escalation of BreAK CRC-001. Nine unresectable patients were treated; 89% had liver metastases and 89% KRAS-mutant tumors, a population refractory to immunotherapy. Median follow-up: 8 months (1–14; data cut-off 6/08/2026). 95% of metastatic colorectal cancers are pMMR/MSS tumors, poorly immunogenic and resistant to immunotherapy. STC-1010, the company’s lead in vivo DC-engager, is designed to make these “cold” tumors visible to immune cells. Safety: no dose-limiting toxicity, only grade 1–2 related adverse events. Clinical activity (seven evaluable patients, RECIST 1.1): 100% disease control, 57% objective response rate (4/7). 43% of patients became operable (3/7): two with no evidence of disease afterward. Molecular profile: ctDNA dropped by up to 97% within two months, TP53 and KRAS mutations near undetectable. Immune activity (first six patients): STC-1010 regimen nearly quadrupled cytotoxi
Takeda Announces Arcotatug Tavatecan (TAK-921) Demonstrated Statistically Significant and Clinically Meaningful Improvements in Overall Survival and Progression-Free Survival in Phase 3 Advanced Gastric Cancer Study23.10.2026 14:30:00 EEST | Press release
Takeda(TSE:4502/NYSE:TAK)announced positive results from the Phase 3 G-HOPE-001 study (NCT06238843) of arcotatug tavatecan (TAK-921; Innovent R&D code: IBI343) in patients with Claudin (CLDN)18.2-positive, previously treated, advanced gastric or gastroesophageal junction adenocarcinoma (G/GEJA). Results from two prespecified interim analyses, which were shared in a late-breaking oral presentation at the 2026 European Society for Medical Oncology (ESMO) Congress, showed the study met its dual primary endpoints of overall survival (OS) and progression-free survival (PFS). Gastric cancer is a leading cause of cancer-related death worldwide, and outcomes are particularly poor once the disease is advanced.1 Because treatment options are limited for people whose cancer continues to progress after multiple therapies, there is a significant need for new targeted therapies.2 CLDN18.2, a protein found at abnormally high levels on the surface of certain cancer cells, has emerged as a key biomarke
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
